CSS
AMGN icon

Cubist Systematic Strategies’s Amgen AMGN Stock Holding History

Cubist Systematic Strategies’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-32,454
Closed -$9.5M – 3670
2023
Q4 		$9.35M Buy
+32,454
New +$8.84M 0.06% 491
2023
Q3 		– Sell
-10,149
Closed -$2.53M – 3298
2023
Q2 		$2.25M Buy
10,149
+7,801
+332% +$1.81M 0.02% 1399
2023
Q1 		$568K Sell
2,348
-101,300
-98% -$24.9M ﹤0.01% 2586
2022
Q4 		$27.2M Buy
103,648
+26,866
+35% +$7.2M 0.16% 65
2022
Q3 		$17.3M Sell
76,782
-119,265
-61% -$28.9M 0.1% 201
2022
Q2 		$47.7M Buy
196,047
+154,500
+372% +$37.9M 0.29% 6
2022
Q1 		$10M Buy
41,547
+5,123
+14% +$1.18M 0.08% 298
2021
Q4 		$8.19M Buy
36,424
+24,122
+196% +$5.09M 0.08% 351
2021
Q3 		$2.62M Buy
12,302
+728
+6% +$168K 0.03% 836
2021
Q2 		$2.82M Buy
11,574
+6,923
+149% +$1.7M 0.03% 868
2021
Q1 		$1.16M Sell
4,651
-14,587
-76% -$3.48M 0.01% 1440
2020
Q4 		$4.42M Buy
19,238
+18,031
+1,494% +$4.16M 0.06% 504
2020
Q3 		$307K Sell
1,207
-382
-24% -$94.6K ﹤0.01% 1981
2020
Q2 		$375K Sell
1,589
-22,610
-93% -$5.16M 0.01% 1728
2020
Q1 		$4.91M Buy
24,199
+12,056
+99% +$2.63M 0.13% 179
2019
Q4 		$2.93M Sell
12,143
-91,095
-88% -$20.1M 0.05% 545
2019
Q3 		$20M Buy
103,238
+51,118
+98% +$9.81M 0.4% 23
2019
Q2 		$9.61M Buy
52,120
+26,916
+107% +$4.82M 0.18% 127
2019
Q1 		$4.79M Buy
25,204
+13,796
+121% +$2.63M 0.16% 141
2018
Q4 		$2.22M Sell
11,408
-8,899
-44% -$1.74M 0.1% 238
2018
Q3 		$4.21M Buy
20,307
+9,277
+84% +$1.83M 0.23% 69
2018
Q2 		$2.04M Sell
11,030
-10,135
-48% -$1.79M 0.1% 240
2018
Q1 		$3.61M Buy
21,165
+13,976
+194% +$2.57M 0.21% 102
2017
Q4 		$1.25M Buy
7,189
+4,072
+131% +$721K 0.07% 380
2017
Q3 		$581K Buy
3,117
+117
+4% +$20.7K 0.03% 735
2017
Q2 		$517K Sell
3,000
-12,218
-80% -$1.99M 0.03% 727
2017
Q1 		$2.5M Buy
15,218
+7,756
+104% +$1.29M 0.18% 111
2016
Q4 		$1.09M Sell
7,462
-32,119
-81% -$4.83M 0.09% 341
2016
Q3 		$6.6M Buy
39,581
+28,835
+268% +$4.88M 0.42% 19
2016
Q2 		$1.64M Buy
+10,746
New +$1.67M 0.09% 264
2016
Q1 		– Sell
-8,118
Closed -$1.32M – 1591
2015
Q4 		$1.32M Sell
8,118
-2,989
-27% -$470K 0.08% 356
2015
Q3 		$1.54M Sell
11,107
-23,732
-68% -$3.74M 0.08% 367
2015
Q2 		$5.35M Buy
34,839
+2,517
+8% +$403K 0.26% 60
2015
Q1 		$5.17M Buy
32,322
+1,925
+6% +$303K 0.25% 66
2014
Q4 		$4.84M Buy
30,397
+28,385
+1,411% +$4.42M 0.26% 53
2014
Q3 		$283K Sell
2,012
-8,754
-81% -$1.14M 0.02% 1139
2014
Q2 		$1.27M Buy
+10,766
New +$1.25M 0.08% 380

Other funds holding AMGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Cubist Systematic Strategies's AMGN Position: Q1 2024 in Review

Cubist Systematic Strategies sold out of Amgen (AMGN) in Q1 2024, closing a stake of 32,454 shares — an estimated $9.5M sold.

Cubist Systematic Strategies first reported a position in AMGN in Q2 2014 and held it in 37 quarters. The position peaked at $47.7M in Q2 2022. 2,715 funds tracked by Wall St. Rank hold AMGN as of Q1 2024.

  • Cubist Systematic Strategies reported no remaining Amgen position as of Q1 2024 after selling out during the quarter.
  • Cubist Systematic Strategies sold 32,454 Amgen shares in Q1 2024, an estimated $9.5M.
  • Cubist Systematic Strategies first reported a position in Amgen in Q2 2014 and held it in 37 quarters.
  • Cubist Systematic Strategies's Amgen position peaked at $47.7M in Q2 2022.
  • 2,715 funds tracked by Wall St. Rank held Amgen as of Q1 2024.

Based on Cubist Systematic Strategies's 13F filing for Q1 2024, filed 15 May 2024.